Published in Mol Cell Proteomics on May 19, 2010
DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol (2011) 1.42
Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl Sci (2012) 1.36
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry. Mol Cell Proteomics (2015) 1.05
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nat Commun (2014) 1.01
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII. Mol Cell Proteomics (2011) 0.93
Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res (2011) 0.91
The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol (2015) 0.86
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A (2016) 0.83
Human Tumor Antigens and Cancer Immunotherapy. Biomed Res Int (2015) 0.81
The 26S proteasome and initiation of gene transcription. Biomolecules (2014) 0.79
Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex. Biomolecules (2014) 0.79
MHC class I-associated peptides derive from selective regions of the human genome. J Clin Invest (2016) 0.77
Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancers. Sci Rep (2016) 0.76
ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules. J Immunol (2016) 0.75
Interpreting gene-expression profiles in transplantation: a critical appraisal. Front Genet (2011) 0.75
Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy. Mol Cell Proteomics (2016) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev (2002) 16.10
WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res (2005) 12.88
RING domain E3 ubiquitin ligases. Annu Rev Biochem (2009) 12.55
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 11.73
The evolutionary dynamics of eukaryotic gene order. Nat Rev Genet (2004) 5.79
InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol (2008) 4.61
Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science (2008) 3.48
The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet (2005) 3.40
The proteasome: a utility tool for transcription? Curr Opin Genet Dev (2006) 3.29
Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol (2003) 3.00
Antigen processing by the proteasome. Nat Rev Mol Cell Biol (2001) 2.93
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med (2009) 2.62
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity (2004) 2.53
Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell (2009) 2.32
Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med (2001) 2.28
A putative stimulatory role for activator turnover in gene expression. Nature (2005) 2.28
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol (2004) 2.27
The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol (2005) 2.24
A practical overview of protein disorder prediction methods. Proteins (2006) 2.18
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity (2000) 2.10
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J (2001) 2.09
Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol (2007) 2.03
Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat Cell Biol (2003) 1.79
Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv Immunol (2006) 1.78
A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods (2001) 1.72
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A (2005) 1.70
Characterizing the N-terminal processing motif of MHC class I ligands. J Immunol (2008) 1.68
Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol (2009) 1.67
The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci U S A (1997) 1.64
Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur J Immunol (2000) 1.61
Integrating epitope data into the emerging web of biomedical knowledge resources. Nat Rev Immunol (2007) 1.59
A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J Immunol Methods (2002) 1.42
The rules of disorder or why disorder rules. Prog Biophys Mol Biol (2009) 1.39
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity (2003) 1.36
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J Immunol (2006) 1.36
LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem Biol (2007) 1.35
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood (2003) 1.35
The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31
All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev (2005) 1.27
The final touches make perfect the peptide-MHC class I repertoire. Immunity (2007) 1.23
T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J Immunol (2006) 1.23
Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol Immunol (2002) 1.11
Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J Immunol (2007) 1.07
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity. Blood (2007) 1.05
Rethinking peptide supply to MHC class I molecules. Nat Rev Immunol (2007) 1.05
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J Immunol (1999) 1.03
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J Immunol (1999) 1.02
Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions. Scand J Immunol (2005) 0.97
The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect Immun (2007) 0.96
Diverse regulatory mechanisms of eukaryotic transcriptional activation by the proteasome complex. Crit Rev Biochem Mol Biol (2008) 0.95
Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics. J Mol Biol (2008) 0.94
Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics (2003) 0.93
Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope. J Immunol (2006) 0.90
Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur J Immunol (2001) 0.90
Self peptides bound by HLA class I molecules are derived from highly conserved regions of a set of evolutionarily conserved proteins. Immunogenetics (1995) 0.86
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int Immunol (2005) 0.84
Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. J Immunol (1995) 0.81
Evolution of the proteasome components. Immunogenetics (1997) 0.80
Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 6.35
Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97
Ptychographic X-ray computed tomography at the nanoscale. Nature (2010) 3.52
Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell (2008) 3.09
Biological imaging by soft x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2005) 2.79
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol (2005) 2.73
Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol (2008) 2.58
Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol (2004) 2.51
Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol (2006) 2.11
NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein. Nature (2010) 1.95
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell (2003) 1.95
The phagosomal proteome in interferon-gamma-activated macrophages. Immunity (2009) 1.95
Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol (2008) 1.89
aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO J (2007) 1.81
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood (2012) 1.79
Quantitative biological imaging by ptychographic x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2009) 1.78
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev (2012) 1.75
ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem (2010) 1.74
IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization. J Immunol (2005) 1.72
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med (2010) 1.69
Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum (2006) 1.69
Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem (2009) 1.68
Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival. Mol Cell (2008) 1.67
Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res (2007) 1.63
ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63
Improvement in peptide detection for proteomics analyses using NanoLC-MS and high-field asymmetry waveform ion mobility mass spectrometry. Anal Chem (2005) 1.60
A comprehensive map of the mTOR signaling network. Mol Syst Biol (2010) 1.59
Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol Microbiol (2002) 1.58
Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell (2008) 1.56
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease. Blood (2010) 1.49
Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes. Blood (2012) 1.46
The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell (2010) 1.44
Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays (2002) 1.43
H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet (2011) 1.43
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev (2010) 1.42
N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40
Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med (2007) 1.40
Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences. J Biol Chem (2007) 1.38
Diffractive imaging of nonperiodic materials with future coherent X-ray sources. J Synchrotron Radiat (2004) 1.37
Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem (2005) 1.34
A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34
Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12. Mol Endocrinol (2007) 1.32
The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med (2008) 1.31
A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med (2009) 1.31
Organelle proteomics: looking at less to see more. Trends Cell Biol (2003) 1.30
MYST protein acetyltransferase activity requires active site lysine autoacetylation. EMBO J (2011) 1.29
The transcription factor encyclopedia. Genome Biol (2012) 1.28
Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution. BMC Genomics (2007) 1.27
Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem (2002) 1.24
Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol (2005) 1.24
Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J (2009) 1.21
Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol (2008) 1.19
Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J Biol Chem (2007) 1.19
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia (2003) 1.19
Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer. J Proteome Res (2009) 1.17
Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor. PLoS One (2011) 1.16
Structural and electrostatic characterization of pariacoto virus: implications for viral assembly. Biopolymers (2009) 1.15
Modulation of the phagosome proteome by interferon-gamma. Mol Cell Proteomics (2007) 1.15
TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB. J Biol Chem (2008) 1.13
Glycopeptide specificity of the secretory protein folding sensor UDP-glucose glycoprotein:glucosyltransferase. EMBO Rep (2003) 1.13
Memory T-lymphocyte survival does not require T-cell receptor expression. Proc Natl Acad Sci U S A (2008) 1.12
Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci Rep (2012) 1.11
An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol Cell Proteomics (2008) 1.09
Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol (2007) 1.09
Molecular characterization of the evolution of phagosomes. Mol Syst Biol (2010) 1.08
Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood (2007) 1.08
Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression. J Cell Biol (2013) 1.08
Comprehensive profiling of histone modifications using a label-free approach and its applications in determining structure-function relationships. Anal Chem (2008) 1.07
Circadian variation of the response of T cells to antigen. J Immunol (2011) 1.07
Structure of the Rtt109-AcCoA/Vps75 complex and implications for chaperone-mediated histone acetylation. Structure (2011) 1.07
A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc Natl Acad Sci U S A (2008) 1.07
T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med (2005) 1.06
Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal Chem (2005) 1.05
Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood (2014) 1.04
The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity (2008) 1.04
Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep (2006) 1.04
A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics (2013) 1.04
The coming of age of phosphoproteomics--from large data sets to inference of protein functions. Mol Cell Proteomics (2013) 1.03
Occurrence and detection of phosphopeptide isomers in large-scale phosphoproteomics experiments. J Proteome Res (2012) 1.03
Drosophila S2 cells secrete wingless on exosome-like vesicles but the wingless gradient forms independently of exosomes. Traffic (2012) 1.03
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood (2002) 1.03
Identification of glycan structure and glycosylation sites in cellobiohydrolase II and endoglucanases I and II from Trichoderma reesei. Glycobiology (2002) 1.03
Corepressor recruitment by agonist-bound nuclear receptors. Vitam Horm (2004) 1.02
The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain (2013) 1.02
ER stress affects processing of MHC class I-associated peptides. BMC Immunol (2009) 1.02
Ptychographic characterization of the wavefield in the focus of reflective hard X-ray optics. Ultramicroscopy (2010) 1.01
Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem (2010) 1.01